Sly Syndrome Terminated Phase 2 Trials for Alemtuzumab (DB00087)

Back to Sly Syndrome

Also known as: Other mucopolysaccharidoses / Mucopolysaccharidosis VII / Mucopolysaccharidosis, MPS-VII (disorder) / Deficiency of beta-glucuronidase (disorder) / Sly's syndrome

Indication	Status	Phase
DBCOND0040268 (Sly Syndrome)	Terminated	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00668564	Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism	Treatment	Alemtuzumab (DB00087) Busulfan (DB01008) Cyclophosphamide (DB00531)